RE:RE:RE:RE:RE:Oncidium acquires $17M medical evaluation firmI believe Cannacord has DOC stacking up a bit like you depict here totaling $88.9MM "in-year 2021" Revenues per their report.
I believe that they are currently at $144MM run rate and will continue to keep piling on top of this number prgressively over the second half of 2021 however, depending on when each first dollar of revenue hits the books, we might get to $100MM "in-year 2021" but mostly fully realized in 2022.
At this point, I am tired of second guessing DOC because they keep pulling $17MM add-ins out of nothing so, $200MM+ run rate going into 2022 is realistic IMHO. A mere $56MM to find :-)...
With Dr Mathur now permanently focused on US expansion - there is no way we arent in for NEWS here very soon. $35MM in cash on hand plus an ability to raise similar as a LoC buys you alot of US footprint in addition to Alberta and Quebec.
Sorry for the verbal diarrhea here